SCHEMBL3845387

SCHEMBL3845387

C[C@H](NC(=S)C1CCCN1C(=O)OC(C)(C)C)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPC1 O15118 2/20 0.47
LMNA P02545 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
FKBP1A P62942 1/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CCR1 P32246 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
UCHL1 P09936 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ATM Q13315 1/20 0.42
USP30 Q70CQ3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845389 1.00 ALDH1A1 (0.52) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL3848741 0.89 ALDH1A1 (0.58) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL3848743 0.89 ALDH1A1 (0.58) ALDH1A1GAAHPGDSMN1; SMN2NPC1
SCHEMBL13374831 0.80 ALDH1A1 (0.60) ALDH1A1GAASMN1; SMN2NPC1LMNA
SCHEMBL28630310 0.80 LMNA (0.61) ALDH1A1SMN1; SMN2NPC1LMNANPSR1
SCHEMBL28626850 0.80 NPC1 (0.54) ALDH1A1SMN1; SMN2NPC1LMNANPSR1
SCHEMBL28923361 0.79 POLB (0.56) ALDH1A1SMN1; SMN2NPC1LMNANPSR1
SCHEMBL4002518 0.78 ALDH1A1 (0.56) ALDH1A1GAASMN1; SMN2NPC1LMNA
SCHEMBL7316045 0.78 NPC1 (0.55) ALDH1A1GAASMN1; SMN2NPC1LMNA
SCHEMBL7316058 0.78 NPC1 (0.55) ALDH1A1GAASMN1; SMN2NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288371-B2 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation PHARMACOPEIA, LLC (US) 2012-10-16 US disclosed
US-20090093472-A1 ORTHO PYRROLIDINE, BENZYL-SUBSTITUTED HETEROCYCLE CCR1 ANTAGONISTS FOR AUTOIMMUNE DISEASES & INFLAMMATION PHARMACOPEIA, INC. (US) 2009-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093472-A1 ORTHO PYRROLIDINE, BENZYL-SUBSTITUTED HETEROCYCLE CCR1 ANTAGONISTS FOR AUTOIMMUNE DISEASES & INFLAMMATION CCR1, CCR4, CCR3 ALDH1A1 931/4885GAA 4414/4885HPGD 1273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.